These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20689416)

  • 1. Role of zinc in the development and treatment of mood disorders.
    Cope EC; Levenson CW
    Curr Opin Clin Nutr Metab Care; 2010 Nov; 13(6):685-9. PubMed ID: 20689416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms contributing to antidepressant zinc actions.
    Nowak G; Szewczyk B
    Pol J Pharmacol; 2002; 54(6):587-92. PubMed ID: 12866713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc deficiency induces enhanced depression-like behaviour and altered limbic activation reversed by antidepressant treatment in mice.
    Whittle N; Lubec G; Singewald N
    Amino Acids; 2009 Jan; 36(1):147-58. PubMed ID: 18975044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of zinc in the pathogenesis and treatment of affective disorders].
    Siwek MS; Wróbel A; Dudek D; Nowak G; Zieba A
    Psychiatr Pol; 2005; 39(5):899-909. PubMed ID: 16358590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc: the new antidepressant?
    Levenson CW
    Nutr Rev; 2006 Jan; 64(1):39-42. PubMed ID: 16491668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc deficiency induces depression-like symptoms in adult rats.
    Tassabehji NM; Corniola RS; Alshingiti A; Levenson CW
    Physiol Behav; 2008 Oct; 95(3):365-9. PubMed ID: 18655800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological characterization and mechanisms of the novel antidepressive- and/or anxiolytic-like substances identified from Perillae Herba].
    Tsuji M; Miyagawa K; Takeuchi T; Takeda H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Aug; 28(4):159-67. PubMed ID: 18800619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of zinc with antidepressants in the forced swimming test in mice.
    Szewczyk B; Brański P; Wierońska JM; Pałucha A; Pilc A; Nowak G
    Pol J Pharmacol; 2002; 54(6):681-5. PubMed ID: 12866724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M; David DJ; Jolliet P; Gardier A
    Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models of depression and neuroplasticity: assessing drug action in relation to behavior and neurogenesis.
    Xu Y; Barish PA; Pan J; Ogle WO; O'Donnell JM
    Methods Mol Biol; 2012; 829():103-24. PubMed ID: 22231809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study.
    Nowak G; Siwek M; Dudek D; Zieba A; Pilc A
    Pol J Pharmacol; 2003; 55(6):1143-7. PubMed ID: 14730113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges and opportunities to manage depression during the menopausal transition and beyond.
    Soares CN; Frey BN
    Psychiatr Clin North Am; 2010 Jun; 33(2):295-308. PubMed ID: 20385338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc and depression. An update.
    Nowak G; Szewczyk B; Pilc A
    Pharmacol Rep; 2005; 57(6):713-8. PubMed ID: 16382189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of pharmacogenetics in the treatment of depression and anxiety disorders.
    Schosser A; Kasper S
    Int Clin Psychopharmacol; 2009 Nov; 24(6):277-88. PubMed ID: 19738481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing new treatments for depression and anxiety.
    Chen Z; Yang J; Tobak A
    IDrugs; 2008 Mar; 11(3):189-97. PubMed ID: 18311656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychological effects of isolation nursing (1): Mood disturbance.
    Davies H; Rees J
    Nurs Stand; 2000 Mar 29-Apr 4; 14(28):35-8. PubMed ID: 11310068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term anxiolytic and antidepressant-like behavioural effects of tiagabine, a selective GABA transporter-1 (GAT-1) inhibitor, coincide with a decrease in HPA system activity in C57BL/6 mice.
    Thoeringer CK; Erhardt A; Sillaber I; Mueller MB; Ohl F; Holsboer F; Keck ME
    J Psychopharmacol; 2010 May; 24(5):733-43. PubMed ID: 19346277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of fatty acids in the development and treatment of mood disorders.
    Owen C; Rees AM; Parker G
    Curr Opin Psychiatry; 2008 Jan; 21(1):19-24. PubMed ID: 18281836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs.
    Palucha A; Pilc A
    Pharmacol Ther; 2007 Jul; 115(1):116-47. PubMed ID: 17582504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. sigma-1 receptors in major depression and anxiety.
    Kulkarni SK; Dhir A
    Expert Rev Neurother; 2009 Jul; 9(7):1021-34. PubMed ID: 19589051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.